Long-term antibody persistence against hepatitis B in adolescents 14–15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy

Long-term antibody persistence against hepatitis B in adolescents 14–15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy

We evaluated antibody persistence against hepatitis B virus (HBV) in adolescents previously vaccinated with a hexavalent diphtheria-tetanus-acellular pertussis-HBV-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine (DTPa-HBV-IPV/Hib), as part of the national newborn immunization...

Full description

Bibliographic Details
Main Authors: Tino F. Schwarz, Ulrich Behre, Thomas Adelt, Matthias Donner, Pemmaraju V. Suryakiran, Winnie Janssens, Narcisa Mesaros, Falko Panzer
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
hepatitis b
anamnestic response
challenge dose
dtpa-hbv-ipv/hib
immune memory
long-term persistence
seroprotection
adolescents
Online Access:http://dx.doi.org/10.1080/21645515.2018.1509658

Internet

http://dx.doi.org/10.1080/21645515.2018.1509658

Similar Items